CG Invites Co., Ltd. Logo

CG Invites Co., Ltd.

A biopharmaceutical company specializing in digital genomics and personalized medicine.

083790 | KO

Overview

Corporate Details

ISIN(s):
KR7083790006
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구

Description

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-31 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.8 MB
2025-08-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 34.7 KB
2025-08-08 00:00
[기재정정]사업보고서 (2024.12)
Korean HTML 2.7 MB
2025-07-25 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 16.5 KB
2025-07-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.3 KB
2025-07-10 00:00
소송등의판결ㆍ결정 (신주발행 무효-취하)
Korean HTML 5.3 KB
2025-07-10 00:00
소속부변경
Korean HTML 3.6 KB
2025-07-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 38.0 KB
2025-07-01 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 14.1 KB
2025-07-01 00:00
소속부변경
Korean HTML 3.6 KB
2025-06-05 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.5 KB
2025-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 28.6 KB
2025-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 29.4 KB
2025-06-05 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB

Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CG Invites Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.